Trade Secrets in the Pharmaceutical Industry

With the enactment of the Defend Trade Secrets Act (DTSA) in 2016, trade secret litigation in federal courts has grown. Yet many companies, including those in the pharmaceutical industry, have not fully realized the potential benefits of supplementing their patent portfolios with trade secrets on certain innovations and surrounding information, processes, research, and techniques.

Once a company identifies the types of information that may benefit from trade secret protection, it can determine how to best protect the information in conjunction with its patented inventions. Companies with trade secrets should proactively protect them, including when making submissions to the USPTO and the FDA.

Join us for a discussion of the latest trends in the law on trade secrets, including considerations for bringing claims in state or federal court, tips for supplementing patent portfolios with trade secret protections, and insights on best protecting trade secrets when making regulatory submissions.

Our panel will discuss the evolving law for pharmaceutical trade secrets, including:

• Identifying trade secrets in the pharmaceutical industry
• Protecting trade secrets, including when making submissions to the USPTO and FDA
• Enforcing trade secrets in state and federal court
• Coordinating patent and trade secret strategies

Recorded: View On-Demand

Speakers:
Shana K. Cyr, Ph.D.
Maximilienne Giannelli, Ph.D.
John M. Williamson

Moderator:
Megan L. Meyers

Date:
October 29, 2019

Time:
10:00 - 11:00 a.m. PDT
1:00 - 2:00 p.m. EDT
18:00 - 19:00 CET

Scheduling Conflict? Finnegan records all hosted webinars. To view the recorded program, simply register for the webinar and you will receive an access link shortly after the live program is complete.